211 related articles for article (PubMed ID: 22137130)
1. CFTR mutation analysis and haplotype associations in CF patients.
Cordovado SK; Hendrix M; Greene CN; Mochal S; Earley MC; Farrell PM; Kharrazi M; Hannon WH; Mueller PW
Mol Genet Metab; 2012 Feb; 105(2):249-54. PubMed ID: 22137130
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite haplotypes for cystic fibrosis: mutation frameworks and evolutionary tracers.
Morral N; Nunes V; Casals T; Chillón M; Giménez J; Bertranpetit J; Estivill X
Hum Mol Genet; 1993 Jul; 2(7):1015-22. PubMed ID: 7689896
[TBL] [Abstract][Full Text] [Related]
3. CFTR haplotypic variability for normal and mutant genes in cystic fibrosis families from southern France.
Claustres M; Desgeorges M; Moine P; Morral N; Estivill X
Hum Genet; 1996 Sep; 98(3):336-44. PubMed ID: 8707306
[TBL] [Abstract][Full Text] [Related]
4. Fluorescent multiplex microsatellites used to define haplotypes associated with 75 CFTR mutations from the UK on 437 CF chromosomes.
Hughes D; Wallace A; Taylor J; Tassabehji M; McMahon R; Hill A; Nevin N; Graham C
Hum Mutat; 1996; 8(3):229-35. PubMed ID: 8889582
[TBL] [Abstract][Full Text] [Related]
5. Haplotype analysis of 94 cystic fibrosis mutations with seven polymorphic CFTR DNA markers.
Morral N; Dörk T; Llevadot R; Dziadek V; Mercier B; Férec C; Costes B; Girodon E; Zielenski J; Tsui LC; Tümmler B; Estivill X
Hum Mutat; 1996; 8(2):149-59. PubMed ID: 8844213
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
[TBL] [Abstract][Full Text] [Related]
7. Extensive sequencing of the CFTR gene: lessons learned from the first 157 patient samples.
McGinniss MJ; Chen C; Redman JB; Buller A; Quan F; Peng M; Giusti R; Hantash FM; Huang D; Sun W; Strom CM
Hum Genet; 2005 Dec; 118(3-4):331-8. PubMed ID: 16189704
[TBL] [Abstract][Full Text] [Related]
8. Current Status of Genetic Diagnosis Laboratories and Frequency of Genetic Variants Associated with Cystic Fibrosis through a Newborn-Screening Program in Turkey.
Bozdogan ST; Mujde C; Boga I; Sonmezler O; Hanta A; Rencuzogullari C; Ozcan D; Altintas DU; Bisgin A
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33572515
[TBL] [Abstract][Full Text] [Related]
9. Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.
Siryani I; Jama M; Rumman N; Marzouqa H; Kannan M; Lyon E; Hindiyeh M
PLoS One; 2015; 10(7):e0133890. PubMed ID: 26208274
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of cystic fibrosis in Lithuania: incomplete CFTR mutation detection by PCR-based screening protocols.
Giannattasio S; Bobba A; Jurgelevicius V; Vacca RA; Lattanzio P; Merafina RS; Utkus A; Kucinskas V; Marra E
Genet Test; 2006; 10(3):169-73. PubMed ID: 17020467
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive cystic fibrosis mutation epidemiology and haplotype characterization in a southern Italian population.
Castaldo G; Polizzi A; Tomaiuolo R; Cazeneuve C; Girodon E; Santostasi T; Salvatore D; Raia V; Rigillo N; Goossens M; Salvatore F
Ann Hum Genet; 2005 Jan; 69(Pt 1):15-24. PubMed ID: 15638824
[TBL] [Abstract][Full Text] [Related]
12. Extended haplotype analysis of cystic fibrosis mutations and its implications for the selective advantage hypothesis.
Sereth H; Shoshani T; Bashan N; Kerem BS
Hum Genet; 1993 Oct; 92(3):289-95. PubMed ID: 7691712
[TBL] [Abstract][Full Text] [Related]
13. XV-2c/KM19 haplotypes analysis of cystic fibrosis patients from western Mexico.
Flores-Martínez SE; Martínez JF; Machorro-Lazo MV; García-Zapién AG; Salgado-Goytia L; Cruz-Quevedo EG; Morán-Moguel MC; Sánchez-Corona J
Acta Physiol Hung; 2008 Sep; 95(3):313-25. PubMed ID: 18788470
[TBL] [Abstract][Full Text] [Related]
14. Improved detection of CFTR mutations in Southern California Hispanic CF patients.
Wong LJ; Wang J; Zhang YH; Hsu E; Heim RA; Bowman CM; Woo MS
Hum Mutat; 2001 Oct; 18(4):296-307. PubMed ID: 11668613
[TBL] [Abstract][Full Text] [Related]
15. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB
Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
[TBL] [Abstract][Full Text] [Related]
16. Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis-associated protein (IRT/PAP) as a strategy that does not involve DNA testing in a Northern European population.
Sommerburg O; Lindner M; Muckenthaler M; Kohlmueller D; Leible S; Feneberg R; Kulozik AE; Mall MA; Hoffmann GF
J Inherit Metab Dis; 2010 Oct; 33(Suppl 2):S263-71. PubMed ID: 20714932
[TBL] [Abstract][Full Text] [Related]
17. Haplotype analysis of the CFTR gene on normal and mutant CFTR genes.
Karimi N; Bidemeshki Pour A; Alibakhshi R; Almasi S
Mutat Res; 2020; 821():111708. PubMed ID: 32563932
[TBL] [Abstract][Full Text] [Related]
18. A haplotype framework for cystic fibrosis mutations in Iran.
Elahi E; Khodadad A; Kupershmidt I; Ghasemi F; Alinasab B; Naghizadeh R; Eason RG; Amini M; Esmaili M; Esmaeili Dooki MR; Sanati MH; Davis RW; Ronaghi M; Thorstenson YR
J Mol Diagn; 2006 Feb; 8(1):119-27. PubMed ID: 16436643
[TBL] [Abstract][Full Text] [Related]
19. Benign and Deleterious Cystic Fibrosis Transmembrane Conductance Regulator Mutations Identified by Sequencing in Positive Cystic Fibrosis Newborn Screen Children from California.
Salinas DB; Sosnay PR; Azen C; Young S; Raraigh KS; Keens TG; Kharrazi M
PLoS One; 2016; 11(5):e0155624. PubMed ID: 27214204
[TBL] [Abstract][Full Text] [Related]
20. Mutational spectrum of cystic fibrosis patients from Córdoba province and its zone of influence: implications of molecular diagnosis in Argentina.
Ramírez AM; Ramos MD; Jiménez J; Ghio A; de Botelli MM; Rezzónico CA; Marqués I; Pereyro S; Casals T; de Kremer RD
Mol Genet Metab; 2006 Apr; 87(4):370-5. PubMed ID: 16423550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
